Antifibrotic Therapy Effective for Certain Patients With PPF

Antifibrotic therapy can extend survival in patients with progressive fibrosing interstitial lung disease (PF-ILD), according to a new study, but it does not necessarily benefit all patients with progressive pulmonary fibrosis (PPF).

The new…